Now I have a thorough understanding of the paper and the reviewer claims. Let me synthesize the final review.

## Summary

The paper proposes a method (conformalized survival counterfactual prediction) for constructing lower prediction bounds (LPBs) on survival time under different treatments, adapted to general right-censored data (not just Type-I censoring). The core idea is to reweight the observed (treated, uncensored) calibration distribution to match the target population using weighted conformal prediction. The paper provides a distribution-free bound on coverage (Theorem 4.1) that depends on the accuracy of estimated density-ratio weights, along with an asymptotic doubly-robust property (Theorem 4.2). Experiments on synthetic data and a real lung-cancer dataset are reported.

## Strengths

1. **Novel and well-motivated methodological contribution.** The paper is the first to apply weighted conformal prediction to counterfactual survival prediction under general right-censoring. The reweighting scheme (Eq. 1, Section 4.1) that transforms the target coverage probability into a weighted conformal inference problem is a principled way to handle the distribution shift from the observed (treated, uncensored) subpopulation to the target population. This cleanly extends prior work that was limited to Type-I censoring or PAC-type guarantees.

2. **Theoretical grounding with honest error quantification.** Theorem 4.1 provides a bound on the coverage error:
   \[
   \mathbb{P}(T(w)\ge\tilde{L}^{(w)}_{N,n}(X))\ge 1-\alpha-\frac12\mathbb{E}_{X|\cdot}[|\tilde{\omega}(X)-\omega(X)|],
   \]
   which explicitly depends on the L1 error in estimating the density-ratio weights. Unlike many conformal papers that sweep estimation error under the rug, this bound is transparent about the finite-sample cost of weight estimation. Theorem 4.2 further establishes an asymptotic doubly-robust property, which is a useful theoretical addition.

3. **Extension to general right-censored data under standard causal assumptions.** Prior conformal survival methods (Candès et al. 2023, Gui et al. 2024) required Type-I censoring (known censoring times). By leveraging the ignorability Assumption 3.1 (which includes conditional independence of censoring), the proposed framework works in the more practical and challenging general right-censored setting.

4. **Empirical validation on synthetic data.** The synthetic experiments (Section 5.1, Figure 1) show the method achieving coverage close to the nominal 90% level across multiple settings, while producing competitive LPB values. The outlier experiment (Figure 3) demonstrates meaningful robustness: PAC-type baselines (Focus, Fused) suffer coverage drops under outliers, while the proposed method maintains near-nominal coverage.

5. **LPB optimization procedure.** The τ-selection step (Section 4.1) that maximizes the LPB for each test point is a practical contribution (Table 1 shows improvement from 0.411 to 0.503 for α=0.05), demonstrating that the framework can produce tighter bounds without sacrificing validity.

## Weaknesses

### Fatal
None.

### Major

1. **Overstatement of the coverage guarantee.** The abstract claims "an LPB … with an exact miscoverage guarantee"; the introduction claims "exact marginally valid LPB" and "distribution-free exact guarantee"; Section 3 says the method "can achieve exact marginal coverage." However, Theorem 4.1 delivers a *lower bound* with an additive error term \(\frac12\mathbb{E}[|\tilde{\omega}-\omega|]\) that can be arbitrarily large if the weight model is misspecified. The guarantee is "distribution-free" in the sense of making no parametric assumptions about the data distribution, but it is not "exact" — it degrades with weight estimation error. The paper repeatedly draws a sharp contrast between its "exact" guarantee and prior PAC-type guarantees, yet the actual finite-sample guarantee involves an uncontrolled error term from weight estimation. This is a meaningful discrepancy between the advertised and actual nature of the theoretical result. The authors should consistently qualify the claim (e.g., "approximate," "depending on weight estimation accuracy") throughout the paper, not only in Theorem 4.1.

2. **Real-data coverage evaluation is unexplained.** Section 5.2 reports coverage rates on a lung-cancer dataset (Figure 4, top row), but never specifies how coverage is assessed when the true survival time is right-censored for a substantial fraction of test patients. For censored patients we only know \(T > C\); the check \(T \ge \text{LPB}\) is not directly evaluable. The paper does not state whether only uncensored test points were used (which would introduce selection bias), whether imputation was employed, or whether a different protocol (e.g., restricting evaluation to patients where \(C \ge \text{LPB}\)) was followed. Without this detail, the coverage numbers on real data are uninterpretable, and the claim of "empirical validation" on clinical data (third contribution bullet) is unsupported as presented. This must be clarified.

### Minor

1. **"Relative LPB" is not defined in the main text.** The term appears in all figure captions and in the Results text (lines 158, 236, etc.) with only the vague description "the larger the relative LPB, the more informative it is." The reader cannot determine what this metric represents (ratio to an oracle LPB? ratio to some baseline LPB? what oracle?) or whether comparisons across methods on this metric are meaningful. A precise definition should be given in the main text.

2. **Derivation of the key transformation (Eq. 1) is hard to follow.** Steps (ii)→(iii) multiply by \(1/p(e=1|x,W=w)\) and use Lemma A.1 to replace the unconditional probability with a joint probability containing \(e=1\). The logical flow from "we want to bound \(\mathbb{P}(T(w)\le\ldots)\)" to "we can solve a weighted conformal problem" is present, but several intermediate steps are opaque without cross-referencing the appendix (e.g., the role of Lemma A.1, the move from unconditional to conditional-on-\(e=1\) expectations). The derivation could be restructured or annotated to make the key insight — that the problem reduces to weighted conformal under \(\mathbb{P}_X \times \mathbb{P}_{T|W=w,e=1,X}\) — more immediately clear.

3. **Limited discussion of the high-dimensional real-data setting.** The lung-cancer dataset has 541 patients and 124 features, yet the paper does not discuss overfitting, variable selection, or regularization for either the quantile regression (MLP with only "one hidden layer" in simulation but "three hidden layers" on real data) or the weight estimation (Random Forest). Given that the core theoretical results depend on accurate density-ratio estimation, the practical challenges of weight estimation in this \(p \approx n/4\) regime deserve at least a brief acknowledgment.

4. **Theorem 4.2 (doubly robust) is asymptotic.** The doubly-robust property is a nice theoretical addition, but it is stated as a limit result (\(N,n\to\infty\)) under regularity conditions. Its practical relevance for realistic sample sizes is not evaluated or discussed.

5. **"Naive," "Focus," "Fused" baselines are described only by name in the main text.** While implementation details likely reside in the appendix, the main text should provide a one‑sentence description of each to make the comparison interpretable without cross-referencing.

### Trivial
None.

## Nice-to-Haves

- A simulation where the weight model is intentionally misspecified would provide a more honest and informative picture of how coverage degrades, complementing the outlier experiment.
- Error bars or confidence intervals for the LPB comparisons (e.g., across the 50 independent trials) would strengthen the quantitative comparison.
- The adaptive cut‑off method derivation in Section 3 could be shortened since it is background, not directly used.

## Removed Points

- **Alleged inconsistency between text and Figure 1:** The reviewer claimed the figure contradicts the text (Fused having higher LPB than Ours in settings 3–5). This cannot be verified from the text-only representation of the figure (the parser strips visual content). The textual description alone does not support or refute the claim, so this criticism is removed.
- **Reproducibility concerns about baselines, hyperparameters, etc.:** These details likely reside in the appendix (which is stripped by the parser). Per instructions, missing appendix content is not a valid criticism.
- **Style nitpicks (e.g., Section 3 being too long, generic phrases like "high‑stakes clinical scenarios"):** These are presentation preferences, not substantive weaknesses.
- **Criticism that Theorem 4.1 is "not distribution‑free":** The bound is indeed distribution‑free in the conformal sense (no parametric assumptions on the data distribution). The dependence on weight estimation error is a separate issue from distribution‑freeness.
- **Claim that Figure 2 contradicts something:** The figure description shows Ours producing lower relative LPB (better/closer to 1.0) than baselines, which is consistent with the text.

## Novel Insights

None beyond the paper's own contributions. The review process surfaces the tension between the "exact" language used in the narrative and the error-dependent bound in Theorem 4.1, which is a genuine disconnect worth the authors' attention.

## Suggestions

1. **Tone down the "exact" claims.** Replace "exact miscoverage guarantee" with "distribution-free bound on miscoverage" or "approximate marginal coverage depending on weight estimation accuracy" throughout the abstract and introduction. Be precise about what is exact (weighted conformal conditional on known weights) and what is approximate (the overall procedure with estimated weights).
2. **Clarify real-data coverage evaluation.** Specify exactly how coverage is computed on censored test patients. If only uncensored patients are used, acknowledge the selection bias and discuss its direction. Alternatively, use a proper evaluation protocol (e.g., IPCW-weighted coverage assessment).
3. **Define "relative LPB" explicitly** in the main text (e.g., LPB divided by the oracle LPB or by the LPB of a reference method) so the metric is interpretable.
4. **Add a brief discussion** of practical challenges for weight estimation with 124 features and 541 patients.
5. **Restructure the derivation in Eq. (1)** to make the key logical steps clearer — in particular, why the inequality in step (iii) is needed and how the final expression maps onto weighted conformal prediction.

## Score and Decision

The paper addresses an important and well-motivated problem, contributes a principled extension of weighted conformal prediction to counterfactual survival with general right-censoring, and provides honest theoretical bounds. However, the presentation systematically overstates the nature of the guarantee ("exact" vs. error-dependent), and the real-data coverage evaluation is described incompletely, leaving a key part of the empirical validation unverifiable. These issues are fixable with careful revision but detract from the paper in its current form.

**Score:** 6.0

**Decision:** Accept

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>